LAMAR; Janine

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAMAR; Janine.The latest application filed is for "anti-il-36r antibodies for the treatment of neutrophilic dermatoses".

Company Profile

12.8.18

LAMAR; Janine - Ingelheim am Rhein DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-il-36r Antibodies For The Treatment Of Neutrophilic Dermatoses App 20220073628 - FINE; Jay ; et al.	2022-03-10
Anti-il-36r Antibodies For The Treatment Of Atopic Dermatitis App 20220010022 - FLACK; Mary Ruth ; et al.	2022-01-13
Pharmaceutical Formulation Comprising Ciclesonide App 20210106685 - AVEN; Michael ; et al.	2021-04-15
Use Of Anti-il-36r Antibodies For Treatment Of Generalized Pustular Psoriasis App 20210087285 - THOMA; Christian ; et al.	2021-03-25
Use Of Anti-il-36r Antibodies For Treatment Of Inflammatory Bowel Disease App 20210061901 - BOECHER; Wulf Otto ; et al.	2021-03-04
Pharmaceutical formulation comprising ciclesonide Grant 10,925,964 - Aven , et al. February 23, 2	2021-02-23
Anti-il-36r Antibodies For Treatment Of Palmoplantar Pustulosis App 20200207862 - BAUM; Patrick ; et al.	2020-07-02
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses Grant 10,682,345 - Albrecht , et al.	2020-06-16
Ciclesonide for the treatment of airway disease in horses Grant 10,441,597 - Albrecht , et al. Oc	2019-10-15
Use Of Anti-il-36r Antibodies For Treatment Of Generalized Pustular Psoriasis App 20190284285 - Thoma; Christian ; et al.	2019-09-19
Use Of Anti-il-36r Antibodies For Treatment Of Inflammatory Bowel Disease App 20190284273 - BOECHER; Wulf Otto ; et al.	2019-09-19
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses App 20190262329 - ALBRECHT; Balazs ; et al.	2019-08-29
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses Grant 10,342,789 - Albrecht , et al. July 9, 2	2019-07-09
Ciclesonide for the treatment of airway disease in horses Grant 10,258,634 - Albrecht , et al.	2019-04-16
Ciclesonide for the Treatment of Airway Disease in Horses App 20180153907 - ALBRECHT; Balazs ; et al.	2018-06-07
Ciclesonide for the treatment of airway disease in horses Grant 9,918,995 - Albrecht , et al. March 20, 2	2018-03-20
Ciclesonide For The Treatment Of Airway Disease In Horses App 20170079988 - ALBRECHT; Balazs ; et al.	2017-03-23
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses App 20170007593 - ALBRECHT; Balazs ; et al.	2017-01-12
Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses Grant 9,474,747 - Albrecht , et al. October 25, 2	2016-10-25
Muscarinic Antagonists And Combinations Thereof For The Treatment Of Airway Disease In Horses App 20150366855 - ALBRECHT; Balazs ; et al.	2015-12-24
Ciclesonide For The Treatment Of Airway Disease In Horses App 20150313918 - ALBRECHT; Balazs ; et al.	2015-11-05
Pharmaceutical Formulation Comprising Ciclesonide App 20140179650 - AVEN; Michael ; et al.	2014-06-26
Ciclesonide For The Treatment Of Airway Disease In Horses App 20140179651 - ALBRECHT; Balazs ; et al.	2014-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.